Anti-vaccine sentiment may derail vaccines already awaiting FDA approval, experts fear
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
Clinical Pain Advisor1h
FDA Delays Final Approval of Novavax COVID Vaccine
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
2 Beaten-Down Stocks That Still Aren't Worth Buying
President Trump's trade policies are sending many stocks that were performing well in the wrong direction and exacerbating ...
Fierce Biotech18h
'A slow-moving catastrophe': FDA cuts are like firing all hospital staff except doctors, Janet Woodcock says
Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...
PharmiWeb22h
Vaccines Market (2024-2035) – A Comprehensive Industry Analysis
Market OverviewThe global Vaccines Market has evolved significantly in recent years, driven by advancements in biotechnology, ...
Taiwan News16h
Asia Pacific Preventive Vaccines Market to Soar from USD 20.9 Billion in 2023 to USD 63.11 Billion by 2032, Registering a Robust CAGR of 13.07%
The Asia Pacific Preventive Vaccines Market is experiencing a transformative surge, with its valuation leaping from USD 20.9 billion in 2023 to a projected USD 63.11 billion by 2032, growing at a ...